Clinical study of Fukeyangrong capsules in the treatment of kidney deficiency and blood stasis type of ovarian reserve dysfunction infertility

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPC-15005870

Enrollment

Unknown

Registered

2015-01-22

Start date

2015-02-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The ovarian reserve function decline

Interventions

1:Fukeyangyan Capsul

2:Fukeyangyan Capsul + Hormone replacement therapy

3:Hormone replacement therapy

Eligibility

Sex/Gender

Female

Age

25 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Determination of basal hormone levels meet at least one of following 3 items: (1) 10U/L FSH more than 10U/L and less than 40U/L; (2) FSH/LH more than 3.6; (3) E2 more than 80pg/ml. 2. Ultrasonic Doppler examination meet at least one of following four items: (1) Side ovarian volume less than 3cm3; (2) Ovary diameter0.65; Resistance index or The systolic peak/Diastolic low value ratio >2.0.

Exclusion criteria

Exclusion criteria: 1. Ovarian tissue implement qualitative sex pathological change and hyperprolactinemia, and other systemic diseases, hypothyroidism; 2. Lipiodol angiography confirmed bilateral fallopian tube obstruction by the uterus and fallopian tube; 3. Infertility caused by male factors;

Design outcomes

Primary

Measure	Time frame
E2;FSH;LH;NHB;AMH;AFC;The volume of ovary;The rate of pregnancy;	—

Countries

China

Contacts

Public ContactXu Xian

xux36@163.com+86 13639579709

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026